• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[普雷斯塔里姆和洛米尔在高血压患者长期治疗中的疗效比较及耐受性]

[Comparative efficacy of and tolerance to prestarium and lomir in long-term treatment of hypertensive subjects].

作者信息

Nesterov Iu I, Ivanova I V, Gol'dberg G A

出版信息

Klin Med (Mosk). 1998;76(3):41-3.

PMID:9575747
Abstract

An antihypertensive action and tolerance of prestarium and lomir were studied in 31 and 33 hypertensive patients, respectively. They had hypertension stage I-II and took the drug for 12 months. Monotherapy with prestarium in a dose 8 mg/day and lomir (10 mg/day) given twice a day provides a complete hypotensive effect for a year in 56 and 62% of patients, respectively. Combinations prestarium + ariphon, lomir + anapriline or verapamil increased the above number to 100%. The occurrence of side effects of long-term lomir monotherapy was 4 times higher than due to prestarium therapy (39.4 versus 9.7%, respectively).

摘要

分别在31例和33例高血压患者中研究了普雷斯他明和洛米尔的降压作用及耐受性。这些患者处于I-II期高血压,服用药物12个月。每日8毫克剂量的普雷斯他明单药治疗以及每日两次服用洛米尔(10毫克/天)分别使56%和62%的患者在一年内获得完全降压效果。普雷斯他明+阿利芬、洛米尔+阿那普利或维拉帕米的联合用药使上述比例提高到100%。长期洛米尔单药治疗的副作用发生率比普雷斯他明治疗高4倍(分别为39.4%和9.7%)。

相似文献

1
[Comparative efficacy of and tolerance to prestarium and lomir in long-term treatment of hypertensive subjects].[普雷斯塔里姆和洛米尔在高血压患者长期治疗中的疗效比较及耐受性]
Klin Med (Mosk). 1998;76(3):41-3.
2
[Long-term monotherapy with prestarium, anap and lomir in patients with mild and moderate arterial hypertension: clinical efficacy, hemodynamics and morphofunctional parameters of heart].[轻度和中度动脉高血压患者使用普雷斯他明、阿纳普和洛米尔的长期单一疗法:心脏的临床疗效、血流动力学和形态功能参数]
Ter Arkh. 1998;70(9):64-7.
3
[Prestarium treatment of essential hypertension].[原发性高血压的Prestarium治疗]
Klin Med (Mosk). 1998;76(9):52-4.
4
Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.与接受伊拉地平或甲基多巴单药治疗或联合卡托普利治疗的高血压男性相比,血压正常男性的生活质量:LOMIR-MCT-IL研究。
J Hum Hypertens. 1996 Feb;10(2):117-22.
5
Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.血管紧张素转换酶抑制剂与钙拮抗剂联合使用能否控制高血压并改善生活质量?LOMIR-MCT-IL研究经验。
Blood Press Suppl. 1994;1:40-2.
6
A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).一项为期26周的前瞻性、开放标签、非对照、多中心研究,旨在评估逐步递增剂量的群多普利方案对初治和同时接受治疗的成年高血压受试者血压变化的影响(TRAIL研究)。
Clin Ther. 2007 Feb;29(2):305-15. doi: 10.1016/j.clinthera.2007.02.016.
7
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.与钙通道阻滞剂单药治疗相比,初始血管紧张素转换酶抑制剂/钙通道阻滞剂联合治疗在2级高血压患者中能实现更好的血压控制。
Am J Hypertens. 2004 Jun;17(6):495-501. doi: 10.1016/j.amjhyper.2004.02.003.
8
[24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].[血管紧张素转换酶抑制剂培哚普利(百普乐)治疗轻至中度高血压的24小时疗效及耐受性。一项为期1年的捷克和斯洛伐克研究]
Vnitr Lek. 1995 Jul;41(7):441-4.
9
Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.高血压肾移植受者的肾血流动力学:钙拮抗剂和血管紧张素转换酶抑制剂的作用
Kidney Int Suppl. 1996 Jun;55:S97-100.
10
[Use of prestarium (perindopril) in patients with polymorbidity syndrome (AH, DM, nephropathy)].培哚普利在患有多种疾病综合征(高血压、糖尿病、肾病)患者中的应用
Klin Med (Mosk). 2009;87(10):61-2.